Vascular calcification (VC) is a crucial risk factor for cardiovascular diseases (CVD), particularly in chronic kidney disease (CKD) populations. However, the specific relationship between VC and end-stage renal disease (ESRD) patients undergoing peritoneal dialysis (PD) remains to be fully understood. The identification of new biomarkers to improve VC diagnosis and monitoring would significantly impact cardiov...
Accelerated and premature cardiovascular calcification is a hallmark of chronic kidney disease (CKD) patients. Valvular calcification (VC) is a critical indicator of cardiovascular disease and all-cause mortality in this population, lacking validated biomarkers for early diagnosis. Gla-rich protein (GRP) is a cardiovascular calcification inhibitor recently associated with vascular calcification, pulse pressure,...
Peritoneal protein loss (PPL) has been correlated with mortality, malnutrition and inflammation. More recently overhydration was brought to the equation. This study aims to review classic and recent factors associated with PPL. Prevalent and incident peritoneal dialysis (PD) patients were included. Dialysate and serum IL-6 was obtained during PET. Hydration and nutritional status were assessed by bio-impedance....
Accelerated and premature cardiovascular calcification is a hallmark of chronic kidney disease (CKD) patients. Valvular calcification (VC) is a critical indicator of cardiovascular disease and all-cause mortality in this population, lacking validated biomarkers for early diagnosis. Gla-rich protein (GRP) is a cardiovascular calcification inhibitor recently associated with vascular calcification, pulse pressure,...
Vascular calcification (VC) is one of the strongest predictors of cardiovascular risk in chronic kidney disease (CKD) patients. New diagnostic/prognostic tools are required for early detection of VC allowing interventional strategies. Gla-rich protein (GRP) is a cardiovascular calcification inhibitor, whose clinical utility is here highlighted. The present study explores, for the first time, correlations betwee...
In the last 13 years, PNAEQ provided a specific program on post-analytical phase. In order to raise the offer of schemes in areas like Thrombosis/ Haemostasis, PNAEQ has established a consortium with ECAT Foundation distributing two more schemes: Post- Analytical Platelet Function and Pre- and Post-Analytical in Haemostasis. Furthermore, five of the analytical schemes organized by PNAEQ include a post-analytica...
A fase pré-analítica tem como objetivo obter amostras de qualidade e em segurança para o técnico e o utente. Cabe ao laboratório implementar um sistema de deteção, monitorização e redução ou eliminação de erros com impacto nos resultados laboratoriais e na saúde do utente. Estas ferramentas são fornecidas no programa de AEQ da fase pré-analítica do PNAEQ, cuja taxa de participação é baixa. A realização de dois ...
1. Fase Pré-Analítica 2. Apresentações Potássio e Pré analítica – Gizela Santos Pré analítica em Microbiologia – Vitória Rodrigues Elaboração e interpretação de Matriz de risco no âmbito da Pré analítica – Rosário Luís Incertezas associadas à variabilidade fase Pré analítica – Marília Faísca Discussão 3. Pré-Analítica e participação em programas de AEQ
Since the population in the developed world is aging, the burden offragility fractures is aconstantly increasing problem. Despite the fact that potent bone-specific pharmaceutical agents have become available, the problem of how to identify patients with high fracture risk yet remains an enigma. Some studies mention the role of a normal mineral metabolism is critical for skeletal development and preservation of...